Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

Authors: Simonsson, Bengt, Gedde-Dahl, Tobias, Markevärn, Berit, Remes, Kari, Stentoft, Jesper, Almqvist, Anders, Björeman, Mats, Flogegård, Max, Koskenvesa, Perttu, Lindblom, Anders, Malm, Claes, Mustjoki, Satu, Myhr-Eriksson, Kristina, Ohm, Lotta, Räsänen, Anu, Sinisalo, Marjatta, Själander, Anders, Strömberg, Ulla, Bjerrum, Ole Weiss, Ehrencrona, Hans, Gruber, Franz, Kairisto, Veli, Olsson, Karin, Sandin, Fredrik, Nagler, Arnon, Nielsen, Johan Lanng, Hjorth-Hansen, Henrik, Porkka, Kimmo

Source: In Blood 22 September 2011 118(12):3228-3235

Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients.

Authors: Schöllkopf, Claudia, Kjeldsen, Lars, Bjerrum, Ole Weiss, Mourits-Andersen, Hans Torben, Nielsen, Johan Lanng, Christensen, Bjarne Egelund, Jensen, Bjarne Anker, Pedersen, Bjarne Bach, Taaning, Ellen Birkerod, Klausen, Tobias Wirenfeldt, Birgens, Henrik

Source: Leukemia & Lymphoma; Feb2006, Vol. 47 Issue 2, p253-260, 8p, 1 Chart, 1 Graph

Subject Terms: COLD agglutinin syndrome, RITUXIMAB, AGGLUTININS, BLOOD diseases, AGGLUTINATION, ANTINEOPLASTIC agents, MONOCLONAL antibodies

Favorable Therapeutic Responses in Newly Diagnosed CML-CP Patients Induced by Dasatinib Are Reflected At the CD34+CD38+ Progenitor Cell but Not At the CD34+CD38− Stem Cell Level: Results From Randomized NordCML006 Study

Authors: Mustjoki, Satu, Richter, Johan ^*, Barbany, Gisela ^*, Ehrencrona, Hans ^*, Dybedal, Ingunn ^*, Fioretos, Thoas, Gedde-Dahl, Tobias ^*, Gjertsen, Bjorn, Hovland, Randi ^*, Jalkanen, Sari E ^*, Josefsen, Dag, Koskenvesa, Perttu ^*, Lassen, Carin ^*, Latvala, Kirsi ^*, Majeed, Waleed ^*, Malm, Claes ^*, Markevärn, Berit ^*, Mosfegh, Ali ^*, Ohm, Lotta ^*, Olofsson, Tor ^*, Olsson-Strömberg, Ulla ^*, Rapakko, Katrin ^*, Remes, Kari ^*, Stentoft, Jesper ^*, Stenke, Leif, Suominen, Merja ^*, Thunberg, Sara ^*, Bjerrum, Ole Weiss ^*, Simonsson, Bengt, Porkka, Kimmo, Hjorth-Hansen, Henrik ^*

Source: In Blood 18 November 2011 118(21):784-784

The Proportion of Ph+ CD34+CD38neg Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Correlates with High Sokal Risk, High Leukocyte Count, Low Hemoglobin Concentration, Splenomegaly and Increased Hematological Toxicity During Initial TKI-Therapy. Data From a Randomized Phase II NordCML006 Study

Authors: Mustjoki, Satu, Richter, Johan ^*, Barbany, Gisela ^*, Dybedal, Ingunn ^*, Fioretos, Thoas ^*, Gedde-Dahl, Tobias ^*, Gjertsen, Bjorn T., Hovland, Randi ^*, Jalkanen, Sari ^*, Josefsen, Dag ^*, Koskenvesa, Perttu ^*, Lassen, Carin ^*, Latvala, Kirsi ^*, Majeed, Waleed ^*, Malm, Claes ^*, Markevärn, Berit ^*, Moshfegh, Ali ^*, Ohm, Lotta ^*, Olofsson, Tor ^*, Olsson-Strömberg, Ulla ^*, Rapakko, Katrin ^*, Remes, Kari ^*, Stentoft, Jesper ^*, Stenke, Leif, Suominen, Merja ^*, Thunberg, Sara ^*, Bjerrum, Ole Weiss ^*, Simonsson, Bengt, Porkka, Kimmo, Hjorth-Hansen, Henrik ^*

Source: In Blood 19 November 2010 116(21):667-667

A Randomized Phase II Study Comparing Imatinib and the Combination of Imatinib and Pegylated Interferon Alpha-2b in Newly Diagnosed Non-High Risk Chronic Myeloid Leukemia (CML) Patients in Complete Hematological Remission After Imatinib Induction Therapy.

Authors: Simonsson, Bengt ^*, Gedde-Dahl, Tobias ^*, Markevärn, Berit ^*, Remes, Kari ^*, Stentoft, Jesper ^*, Almqvist, Anders ^*, Björeman, Mats ^*, Flogegård, Max ^*, Hallman, Heikki ^*, Koskenvesa, Perttu ^*, Lindblom, Anders ^*, Malm, Claes ^*, Mustjoki, Satu, Myhr-Eriksson, Kristina ^*, Räsänen, Anu ^*, Sinisalo, Marjatta ^*, Sippola, Risto ^*, Själander, Anders ^*, Strömberg, Ulla ^*, Bjerrum, Ole Weiss ^*, Ehrencrona, Hans ^*, Gruber, Franz ^*, Kairisto, Veli ^*, Olsson, Karin RN ^*, Nagler, Arnon ^*, Nielsen, Johan Lanng ^*, Hjorth-Hansen, Henrik ^*, Porkka, Kimmo, for the Nordic CML Study Group (NCMLSG)

Source: In Blood 20 November 2009 114(22):3280-3280

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.